NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

This is a lie. Instead, (placebo + SOC) did much much worse than those who received either (DCVax-l + placebo + SOC) or (DCVax-l + SOC). Your analysis is not good. Please do not go into research wanker.

First, I asserted the N=99 arm randomized to placebo lived longer than the N=232 randomized to treatment. That is a fact based on LL 2018 SNO data.

As far as the N=35 patients who never received DCvax-L, we do not know. But there is a bit of a problem with your assertion.

The crossover patients look to have an mOS post randomization of 20,8 months. Treatment is 19.3 months. the weighted average of those is 19,.6 months.

The entire trial is 20,0 months.

So the entire trial was 20,0, the patients who received DC ever where 19.3. And the patients who never recieved it?